NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Biologics API(原藥)製造服務市場報告(2021-2031年):按製造類型,表達平台,應用,區域和主要市場分析,主要企業,COVID-19回收方案進行的預測

Biological Drug API Manufacturing Services Market Report 2021-2031: Forecasts by Manufacturing Type, by Expression Platform, by Application, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 996044
出版日期 內容資訊 英文 353 Pages
商品交期: 最快1-2個工作天內
價格
Biologics API(原藥)製造服務市場報告(2021-2031年):按製造類型,表達平台,應用,區域和主要市場分析,主要企業,COVID-19回收方案進行的預測 Biological Drug API Manufacturing Services Market Report 2021-2031: Forecasts by Manufacturing Type, by Expression Platform, by Application, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios
出版日期: 2021年01月07日內容資訊: 英文 353 Pages
簡介

有機會成為快速發展的生物仿製藥行業的市場領導者,這導致許多公司直接或通過與經驗豐富的CMO合作,投資於生物仿製藥的開發。目前,到2020年,歐盟將有超過55種獲批的生物仿製藥,預計這些產品的市場在未來十年將迅速增長。發達市場和新興市場對低成本生物療法的需求以及重磅炸彈生物製劑專利的到期將推動對生物仿製藥開發的投資。通過提供專業知識和生物製造能力,CMO將受益於與生物仿製藥開發商的合同,這些生物仿製藥開發商如小分子仿製藥商和新興的生物仿製藥廠商正在尋求在發達市場中推出後續生物製劑。

本報告調查了全球生物製劑API(藥品)製造服務市場,除收益預測外,還提供了近期業績,增長率,市場份額和定性分析(市場動態,增長因素,機會,限制)。分析Covid19的影響(包括因素和挑戰)以及主要公司的概況。

目錄

第1章報告概述

第2章執行摘要

第3章行業考慮

  • 促進因素
    • 促進市場增長的生物專利的有效期
    • 外包是推動市場增長的動力
    • 增加對孤兒藥的投資
    • 新興經濟體提供有利的增長機會
    • 一次性技術將在未來十年必不可少
  • 抑制因素
    • 用於生物製劑的製造API可以抑制市場增長
    • 到2031年阻礙市場增長的價格壓力
    • 監管情景抑制市場增長
    • 生產過剩預計會阻礙市場增長
    • 製造API是一項艱鉅的任務
  • SWOT分析
  • 行業分析-PEST分析

第4章按製造類型劃分的生物製劑API(API)製造服務市場

  • 外包領域市場預測
    • 恢復方案(V,U,W,L)
  • 內部細分市場預測
    • 恢復方案(V,U,W,L)

第5章,表達平台的生物製劑API(API)製造服務市場

  • 哺乳動物細胞培養領域的市場預測
    • 簡介
    • 恢復方案(V,U,W,L)
  • 微生物發酵領域市場預測
  • 其他細分市場的預測

第6章按應用分類的生物製劑API(API)製造服務市場

  • 疫苗市場細分市場預測
    • 簡介
    • 恢復方案(V,U,W,L)
  • MAB細分市場預測
  • 胰島素類似物市場細分預測
  • 干擾素治療領域的市場預測
  • 人類生長激素市場的市場預測
  • 其他治療領域細分市場預測

第7章區域和主要國家/地區生物製劑API(原始)製造服務市場預測

  • 全球生物製藥原料藥製造服務市場:區域預測
  • 恢復方案(V,U,W,L)

第8章北美生物製劑API製造服務市場

  • 北美生物製藥原料藥製造服務市場:國家預測
  • 美國生物製劑API(API)製造服務市場預測
    • 全球最大的生物製藥原料藥製造市場
    • FDA於2019年批准的生物製劑
    • 回收情景(V,U,W,L):美國生物製劑API(藥物)製造服務市場預測
  • 加拿大生物製劑API(附件)製造服務市場預測
    • 擴大生物仿製藥在加拿大市場的進入
    • 恢復方案(V,U,W,L):加拿大生物製劑API(原始)製造服務市場預測

第9章歐洲生物製劑API(API)製造服務市場

  • 歐洲生物製藥原料藥製造服務市場:國家預測
  • 德國生物製劑API(藥物)製造服務市場預測
    • 德國擁有成熟的生物製造行業
    • 回收情景(V,U,W,L):德國生物製劑API(藥物)製造服務市場預測
  • 法國生物製劑API(藥物)製造服務市場預測
    • 法國是歐洲主要製藥行業之一
    • 回收情景(V,U,W,L):法國生物製劑API(藥物)製造服務市場預測
  • 英國生物製劑API(API)製造服務市場預測
    • 英國強大的生物製藥行業可推動市場增長
    • 恢復方案(V,U,W,L):英國Biologics API(原始)製造服務市場預測
  • 意大利生物製劑API(藥物)製造服務市場預測
    • 回收情景(V,U,W,L):意大利生物製劑API(藥物)製造服務市場預測
  • 西班牙生物製劑API(藥物)製造服務市場預測
    • 回收情景(V,U,W,L):西班牙生物製劑API(藥物)製造服務市場預測
  • 俄羅斯生物製劑API(藥物)製造服務市場預測
    • 回收情景(V,U,W,L):俄羅斯生物製劑API(藥物)製造服務市場預測
  • 瑞士生物製劑API(API)製造服務市場預測
    • 回收情景(V,U,W,L):瑞士生物製劑API(藥物)製造服務市場預測
  • 荷蘭生物製劑API(藥物)製造服務市場預測
    • 回收情景(V,U,W,L):荷蘭生物製劑API(藥物)製造服務市場預測
  • 其他歐洲生物製劑API(API)製造服務市場預測
    • 回收情景(V,U,W,L):其他歐洲生物製劑API(藥物)製造服務市場預測

第10章亞太生物製劑API製造服務市場

  • 亞太地區生物製藥原料藥製造服務市場:國家預測
  • 日本生物製劑API生產服務市場預測
    • 從原料藥的角度來看,與美國在仿製藥和專利環境以及中國的競爭日益激烈
    • 日本政府削減醫療保健費用以促進仿製藥和生物仿製藥領域
    • 恢復情況(V,U,W,L):日本生物製劑API製造服務市場預測
  • 印度生物製藥原料藥生產服務市場預測
    • 從2021年到2031年,印度的生物製劑API製造服務市場見證了最快的增長速度
    • 印度政府向製藥業注資12億美元,以增強COVID-19中的國內API功能
    • 不斷增長的公共醫療保健部門推動市場增長
    • 復甦方案(V,U,W,L):印度生物製劑API(原始)製造服務市場預測
  • 中國生物製劑API(API)製造服務市場預測
    • 中國是最受歡迎的外包目的地
    • COVID-19中的挑戰
    • 回收情景(V,U,W,L):中國生物製劑API(藥物)製造服務市場預測
  • 澳大利亞生物製藥API(藥物)製造服務市場預測
    • 生物藥學和生物仿製藥的供應有望對澳大利亞的醫療體系產生積極影響
    • 恢復方案(V,U,W,L):澳大利亞生物製劑API(原始)製造服務市場預測
  • 韓國生物製劑API製造服務市場預測
    • 三星生物製劑擴張計劃將為韓國市場提供有利的增長機會
    • 恢復方案(V,U,W,L):韓國Biologics API製造服務市場預測
  • 新加坡生物製劑原料藥製造服務市場預測
    • 不斷發展的製藥業
    • 新加坡全面發展並建立藥品市場
    • 恢復方案(V,U,W,L):新加坡生物製劑API製造服務市場預測
  • 其他亞太地區生物製劑API製造服務市場預測
    • 恢復方案(V,U,W,L):其他亞太地區生物製劑API製造服務市場預測

第11章拉丁美洲生物製劑API(原始)製造服務市場

  • 拉丁美洲生物製藥原料藥製造服務市場:國家預測
  • 巴西生物製劑API(API)製造服務市場預測
    • 恢復方案(V,U,W,L):巴西Biologics API製造服務市場預測
  • 阿根廷生物製劑API(藥物)製造服務市場預測
    • 恢復方案(V,U,W,L):阿根廷生物製劑API(原始)製造服務市場預測
  • 墨西哥生物製劑API(API)製造服務市場預測
    • 簡介
    • 恢復方案(V,U,W,L):墨西哥Biologics API(原始)製造服務市場預測
  • 哥倫比亞Biologics API製造服務市場預測
    • 恢復方案(V,U,W,L):Columbia Biologics API製造服務市場預測
  • 其他拉丁美洲生物製劑API(API)製造服務市場預測
    • 回收情景(V,U,W,L):其他拉丁美洲生物製劑API(藥物)製造服務市場預測

第12章中東和非洲生物製劑API製造服務市場

  • 中東和非洲生物製藥原料藥製造服務市場:國家預測
  • 海灣合作委員會國家生物製劑API製造服務市場預測
    • 恢復方案(V,U,W,L):GCC Biologics API製造服務市場預測
  • 南非Biologics API製造服務市場預測
    • 復甦方案(V,U,W,L):南非生物製劑API製造服務市場預測
  • 中東/非洲其他中東生物製劑API製造服務市場預測
    • 復甦情景(V,U,W,L):中東/非洲其他中東生物製劑API製造服務市場預測

第13章公司簡介

  • Bristol-Myers Squibb Co.
  • Samsung Biologics Co., Ltd.
  • Abbvie Inc.
  • GlaxoSmithKline Plc
  • Lonza Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Nektar Therapeutics
  • UCB SA
  • Biogen Inc.
  • Biocon
  • Regeneron Pharmaceuticals, Inc.
  • Sandoz
  • Fujifilm Diosynth Biotechnologies

第14章 結論

目錄
Product Code: PHA1027

Title:
Biological Drug API Manufacturing Services Market Report 2021-2031
Forecasts by Manufacturing Type (Outsourced, In-house), by Expression Platform (Mammalian Cell Cultures, Microbial Fermentations, Others), by Application (Vaccines, MABs, Insulin Analogues, Interferon Therapies, Human Growth Hormones, Other Therapeutic Areas) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Biological Drug API Manufacturing Companies AND COVID-19 Recovery Scenarios.

Biological Drug API Manufacturing Services Set to Witness Significant Growth Over Next 10 Years

The opportunity to become a market leader in the rapidly growing biosimilar industry has spurred many companies to invest in biosimilar development, either directly or through a partnership with a more experienced CMO. Currently, in 2020, there are over 55 approved biosimilars in the EU and the market for these products is expected to grow rapidly in the coming 10 years. Demand for lower-cost biological therapies in developed and emerging markets, as well as patent expires for blockbuster biologics, will drive investment in biosimilar development. CMOs that can offer expertise and biomanufacturing capacity will benefit from contracts with biosimilar developers, such as small molecule generic drug manufacturers, as well as emerging biosimilar manufacturers looking to launch their follow-on biologics in developed markets.

U.S. Holds the Maximum Market Share in Global Biological Drug API Manufacturing Services Market

The US is the global leader of the biological drug API manufacturing service market and this is no surprise as it also has the highest level of demand worldwide for pharmaceuticals, including outsourced API manufacturing. Per person, the US spends around one thousand dollars a year on pharmaceuticals, higher than any other country in the world. Additionally, pharmaceuticals cost more in the US, with some drugs being twice the price they are in the UK and Canada. This is because the US government does not regulate its pharma prices. Furthermore, the opaque US health system makes it hard to draw drug-by-drug comparisons with prices abroad. The majority of the leading biotech CMOs have facilities in the United States, which provide APIs domestically. In 2020, US market accounted for US$ xx million, or over 90%, of the North American biological drug API manufacturing services revenues. Emerging markets are no longer as cheap as they used to be and additionally, emerging markets do not always meet quality standards. This deficiency in standards and rise in costs because of the demands for compliance to standards has increased the demand in the US market. Local manufacturers can also provide products more conveniently, as there are less communication or timing issues.

Discover how to stay ahead

Our 350+ page report provides 350+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biological Drug API Manufacturing Services Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets.

By Manufacturing Type

  • Outsourced
  • In-house

By Expression Platform

  • Mammalian Cell Cultures
  • Microbial Fermentations
  • Others

By Application

  • Vaccines
  • MABs
  • Insulin Analogues
  • Interferon Therapies
  • Human Growth Hormones
  • Other Therapeutic Areas

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Switzerland
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Singapore
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Biological Drug API Manufacturing Services Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biological Drug API Manufacturing Services Market report helps you

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Biological Drug API Manufacturing Services Market, with forecasts for Manufacturing Type, Expression Platform, and Application, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 22 key national markets- See forecasts for the Biological Drug API Manufacturing Services market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market. Some of the company's profiled in this report include Bristol-Myers Squibb Co., Samsung Biologics, AbbVie, GSK Biopharmaceuticals, Lonza Group Ltd., NEKTAR THERAPEUTICS, Boehringer, Patheon N.V., Cytovance Biologics, and Fujifilm Diosynth Biotechnologies.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biological Drug API Manufacturing Services Market and leading companies. You will find data, trends, and predictions.

Buy our report today " Biological Drug API Manufacturing Services Market Report 2021-2031: Forecasts by Manufacturing Type (Outsourced, In-house), by Expression Platform (Mammalian Cell Cultures, Microbial Fermentations, Others), by Application (Vaccines, MABs, Insulin Analogues, Interferon Therapies, Human Growth Hormones, Other Therapeutic Areas) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Biological API Manufacturing Services Companies AND COVID-19 Recovery Scenarios". Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Biological Drug API Manufacturing Services Market
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered By This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 COVID-19 Impact: Recovery Scenarios
    • 1.6.2 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Executive Summary

3 Industry Insights

  • 3.1 Drivers
    • 3.1.1 Biological Patent Expirations to Fuel Market Growth
    • 3.1.2 Outsourcing as a Driver for Market Growth
    • 3.1.3 Growing Investments in Orphan Drugs
    • 3.1.4 Emerging Economies to Offer Lucrative Growth Opportunities
    • 3.1.5 Single Use Technology will Become Essential Over the Next Decade
  • 3.2 Restraints
    • 3.2.1 Manufacturing APIs for Biologics to Restrain Market Growth
    • 3.2.2 Pricing Pressure to Impede Market Growth Through 2031
    • 3.2.3 Regulatory Scenarios to Restrain Market Growth
    • 3.2.4 Excessive Production is Projected to Impede Market Growth
    • 3.2.5 API Production is a Challenging Task
  • 3.3 SWOT Analysis
    • 3.3.1 Strengths
    • 3.3.2 Weaknesses
    • 3.3.3 Opportunities
    • 3.3.4 Threats
  • 3.4 Industry analysis - PEST Analysis
    • 3.4.1 Political
    • 3.4.2 Economical
    • 3.4.3 Social
    • 3.4.4 Technological

4 Biological Drug API Manufacturing Services Market by Manufacturing Type

  • 4.1 Outsourced Segment Market Forecast, 2021-2031
    • 4.1.1 Recovery Scenarios (V, U, W, L)
  • 4.2 In-house Segment Market Forecast, 2021-2031
    • 4.2.1 Recovery Scenarios (V, U, W, L)

5 Biological Drug API Manufacturing Services Market by Expression Platform

  • 5.1 Mammalian Cell Cultures Segment Market Forecast, 2021-2031
    • 5.1.1 Introduction
    • 5.1.2 Recovery Scenarios (V, U, W, L)
  • 5.2 Microbial Fermentations Segment Market Forecast, 2021-2031
    • 5.2.1 Introduction
    • 5.2.2 Recovery Scenarios (V, U, W, L)
  • 5.3 Others Segment Market Forecast, 2021-2031
    • 5.3.1 Introduction
    • 5.3.2 Recovery Scenarios (V, U, W, L)

6 Biological Drug API Manufacturing Services Market by Application

  • 6.1 Vaccines Segment Market Forecast, 2021-2031
    • 6.1.1 Introduction
    • 6.1.2 Recovery Scenarios (V, U, W, L)
  • 6.2 MABs Segment Market Forecast, 2021-2031
    • 6.2.1 Introduction
    • 6.2.2 Recovery Scenarios (V, U, W, L)
  • 6.3 Insulin Analogues Segment Market Forecast, 2021-2031
    • 6.3.1 Introduction
    • 6.3.2 Recovery Scenarios (V, U, W, L)
  • 6.4 Interferon Therapies Segment Market Forecast, 2021-2031
    • 6.4.1 Introduction
    • 6.4.2 Recovery Scenarios (V, U, W, L)
  • 6.5 Human Growth Hormones Segment Market Forecast, 2021-2031
    • 6.5.1 Introduction
    • 6.5.2 Recovery Scenarios (V, U, W, L)
  • 6.6 Other Therapeutic Areas Segment Market Forecast, 2021-2031
    • 6.6.1 Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Biological Drug API Manufacturing Services Market Forecasts 2021-2031

  • 7.1 Global Biological Drug API Manufacturing Services Market by Region Forecast 2021-2031
  • 7.2 Recovery Scenarios (V, U, W, L)

8 North America Biological Drug API Manufacturing Services Market, 2021-2031

  • 8.1 North America Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
  • 8.2 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 8.2.1 Largest Biological Drug API Manufacturing Market Across the Globe
    • 8.2.2 Biologics Approved by FDA in 2019
    • 8.2.3 Recovery Scenarios (V, U, W, L): U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 8.3 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 8.3.1 Growing Entrance of Biosimilars in Canadian Market
    • 8.3.2 Recovery Scenarios (V, U, W, L): Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031

9 Europe Biological Drug API Manufacturing Services Market, 2021-2031

  • 9.1 Europe Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
  • 9.2 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.2.1 Germany Has Well Established Biomanufacturing Industry
    • 9.2.2 Recovery Scenarios (V, U, W, L): Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.3 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.3.1 France is one of the Leading Pharmaceutical Manufacturing Industry in Europe
    • 9.3.2 Recovery Scenarios (V, U, W, L): France Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.4 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.4.1 Strong Biopharma Industry Across UK to Fuel Market Growth
    • 9.4.2 Recovery Scenarios (V, U, W, L): UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.5 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.5.1 Recovery Scenarios (V, U, W, L): Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.6 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.6.1 Recovery Scenarios (V, U, W, L): Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.7 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.7.1 Recovery Scenarios (V, U, W, L): Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.8 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.8.1 Recovery Scenarios (V, U, W, L): Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.9 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.9.1 Recovery Scenarios (V, U, W, L): Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 9.10 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 9.10.1 Recovery Scenarios (V, U, W, L): Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031

10 Asia Pacific Biological Drug API Manufacturing Services Market, 2021-2031

  • 10.1 Asia Pacific Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
  • 10.2 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.2.1 Increased Competition from U.S. in Generics and Patented Environment, and China in Terms of API
    • 10.2.2 Japanese Government to Cut Healthcare Costs to Boost Generics and Biosimilar Sectors
    • 10.2.3 Recovery Scenarios (V, U, W, L): Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.3 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.3.1 India Biological Drug API Manufacturing Services Market to Witness Fastest Growth Rate from 2021 to 2031
    • 10.3.2 Infusion of US$ 1.2 billion in Pharmaceutical Industry by Indian Government to Boost Domestic API Capabilities Amid COVID-19
    • 10.3.3 Growing Public Healthcare Sector to Fuel Market Growth
    • 10.3.4 Recovery Scenarios (V, U, W, L): India Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.4 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.4.1 China is Most Popular Outsourcing Destination
    • 10.4.2 Challenges Amid COVID-19
    • 10.4.3 Recovery Scenarios (V, U, W, L): China Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.5 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.5.1 Availability of Biologics & Biosimilar Medicines is Anticipated to Have a Positive Impact on Australian Healthcare System
    • 10.5.2 Recovery Scenarios (V, U, W, L): Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.6 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.6.1 Samsung Biologics Expansion Plan to Offer Lucrative Growth Opportunities for South Korean Market
    • 10.6.2 Recovery Scenarios (V, U, W, L): South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.7 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.7.1 Evolving Pharmaceutical Industry
    • 10.7.2 Singapore Has Well Developed & Established Pharma Market
    • 10.7.3 Recovery Scenarios (V, U, W, L): Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 10.8 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 10.8.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031

11 Latin America Biological Drug API Manufacturing Services Market, 2021-2031

  • 11.1 Latin America Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
  • 11.2 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 11.2.1 Recovery Scenarios (V, U, W, L): Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 11.3 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 11.3.1 Recovery Scenarios (V, U, W, L): Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 11.4 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 11.4.1 Introduction
    • 11.4.2 Recovery Scenarios (V, U, W, L): Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 11.5 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 11.5.1 Recovery Scenarios (V, U, W, L): Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 11.6 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 11.6.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031

12 Middle East and Africa Biological Drug API Manufacturing Services Market, 2021-2031

  • 12.1 Middle East and Africa Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
  • 12.2 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 12.2.1 Recovery Scenarios (V, U, W, L): GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 12.3 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 12.3.1 Recovery Scenarios (V, U, W, L): South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
  • 12.4 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
    • 12.4.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031

13 Company Profiles

  • 13.1 Bristol-Myers Squibb Co.
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis, 2015-2019
    • 13.1.4 Product Benchmarking
    • 13.1.5 Recent Developments, 2018-2020
  • 13.2 Samsung Biologics Co., Ltd.
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis, 2015 to 2019
    • 13.2.4 Product Benchmarking
    • 13.2.5 Recent Developments, 2019 to 2020
  • 13.3 Abbvie Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis, 2015 to 2019
    • 13.3.4 Product Benchmarking
    • 13.3.5 Recent Developments, 2018 to 2020
  • 13.4 GlaxoSmithKline Plc
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis, 2015 to 2019
    • 13.4.4 Product Benchmarking
    • 13.4.5 Recent Developments, 2018 to 2020
  • 13.5 Lonza Group
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis, 2015 to 2019
  • 13.6 Teva Pharmaceutical Industries Ltd.
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis, 2015 to 2019
  • 13.7 Piramal Enterprises Ltd
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis, 2015 to 2019
  • 13.8 Boehringer Ingelheim International GmbH
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis, 2015 to 2019
    • 13.8.4 Product Benchmarking
    • 13.8.5 Recent Developments, 2018 to 2020
  • 13.9 Catalent Inc.
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis, 2015 to 2019
  • 13.10 Nektar Therapeutics
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis, 2015 to 2019
    • 13.10.4 Product Benchmarking
    • 13.10.5 Recent Developments, 2018 to 2020
  • 13.11 UCB SA
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis, 2015 to 2019
    • 13.11.4 Product Benchmarking
    • 13.11.5 Recent Developments, 2018 to 2020
  • 13.12 Biogen Inc.
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis, 2015 to 2019
    • 13.12.4 Product Benchmarking
    • 13.12.5 Recent Developments, 2018 to 2020
  • 13.13 Biocon
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis, 2015 to 2019
    • 13.13.4 Product Benchmarking
    • 13.13.5 Recent Developments, 2018 to 2020
  • 13.14 Regeneron Pharmaceuticals, Inc.
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis, 2015 to 2019
    • 13.14.4 Product Benchmarking
    • 13.14.5 Recent Developments, 2018 to 2020
  • 13.15 Sandoz
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Product Benchmarking
    • 13.15.4 Recent Developments, 2018 to 2020
  • 13.16 Fujifilm Diosynth Biotechnologies
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Product Benchmarking
    • 13.16.4 Recent Developments, 2018 to 2020

14 Conclusion

List of Tables

  • Table 1 Global Biological Drug API Manufacturing Services Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
  • Table 2 Global Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 3 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 4 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 5 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 6 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 7 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 8 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 9 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 10 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 11 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 12 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 13 Global Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 14 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 15 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 16 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 17 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 18 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 19 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 20 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 21 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 22 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 23 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 24 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 25 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 26 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 27 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 28 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 29 Global Biological Drug API Manufacturing Services Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 30 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 31 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 32 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 33 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 34 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 35 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 36 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 37 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 38 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 39 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 40 Global Biological Drug API Manufacturing Services Market Forecast for Insulin Analogues, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 41 Global Biological Drug API Manufacturing Services Market Forecast for Insulin Analogues, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 42 Global Biological Drug API Manufacturing Services Market Forecast for Insulin Analogues, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 43 Global Biological Drug API Manufacturing Services Market Forecast for Insulin Analogues, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 44 Global Biological Drug API Manufacturing Services Market Forecast for Insulin Analogues, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 45 Global Biological Drug API Manufacturing Services Market Forecast for Interferon Therapies, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 46 Global Biological Drug API Manufacturing Services Market Forecast for Interferon Therapies, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 47 Global Biological Drug API Manufacturing Services Market Forecast for Interferon Therapies, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 48 Global Biological Drug API Manufacturing Services Market Forecast for Interferon Therapies, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 49 Global Biological Drug API Manufacturing Services Market Forecast for Interferon Therapies, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 50 Global Biological Drug API Manufacturing Services Market Forecast for Human Growth Hormones, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 51 Global Biological Drug API Manufacturing Services Market Forecast for Human Growth Hormones, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 52 Global Biological Drug API Manufacturing Services Market Forecast for Human Growth Hormones, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 53 Global Biological Drug API Manufacturing Services Market Forecast for Human Growth Hormones, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 54 Global Biological Drug API Manufacturing Services Market Forecast for Human Growth Hormones, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 55 Global Biological Drug API Manufacturing Services Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 56 Global Biological Drug API Manufacturing Services Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 57 Global Biological Drug API Manufacturing Services Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 58 Global Biological Drug API Manufacturing Services Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 59 Global Biological Drug API Manufacturing Services Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 60 Global Biological Drug API Manufacturing Services Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 61 Global Biological Drug API Manufacturing Services Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 62 Global Biological Drug API Manufacturing Services Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 63 Global Biological Drug API Manufacturing Services Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 64 Global Biological Drug API Manufacturing Services Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 65 North America Biological Drug API Manufacturing Services Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 66 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 67 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 68 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 69 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 70 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 71 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 72 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 73 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 74 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 75 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 76 Europe Biological Drug API Manufacturing Services Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 77 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 78 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 79 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 80 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 81 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 82 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 83 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 84 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 85 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 86 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 87 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 88 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 89 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 90 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 91 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 92 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 93 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 94 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 95 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 96 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 97 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 98 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 99 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 100 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 101 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 102 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 103 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 104 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 105 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 106 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 107 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 108 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 109 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 110 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 111 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 112 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 113 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 114 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 115 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 116 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 117 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 118 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 119 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 120 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 121 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 122 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 123 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 124 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 125 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 126 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 127 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 128 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 129 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 130 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 131 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 132 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 133 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 134 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 135 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 136 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 137 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 138 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 139 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 140 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 141 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 142 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 143 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 144 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 145 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 146 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 147 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 148 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 149 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 150 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 151 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 152 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 153 Rest of APAC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 154 Rest of APAC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 155 Rest of APAC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 156 Rest of APAC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 157 Rest of APAC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 158 Latin America Biological Drug API Manufacturing Services Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 159 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 160 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 161 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 162 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 163 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 164 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 165 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 166 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 167 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 168 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 169 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 170 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 171 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 172 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 173 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 174 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 175 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 176 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 177 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 178 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 179 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 180 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 181 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 182 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 183 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 184 MEA Biological Drug API Manufacturing Services Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 185 xGCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 186 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 187 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 188 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 189 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 190 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 191 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 192 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 193 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 194 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 195 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 196 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 197 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 198 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 199 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 200 Bristol-Myers Squibb Co.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 201 BRISTOL-MYERS SQUIBB Product Portfolio
  • Table 202 BRISTOL-MYERS SQUIBB: Recent Developments
  • Table 203 Samsung Biologics Co., Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 204 Samsung Biologics Co., Ltd Product Portfolio
  • Table 205 Samsung Biologics Co., Ltd: Recent Developments
  • Table 206 Abbvie Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 207 Abbvie Inc Product Portfolio
  • Table 208 Abbvie Inc: Recent Developments
  • Table 209 GlaxoSmithKline Plc: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 210 GlaxoSmithKline Plc Product Portfolio
  • Table 211 GlaxoSmithKline Plc: Recent Developments
  • Table 212 Lonza Group: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 213 Teva Pharmaceutical Industries Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 214 Piramal Enterprises Ltd: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 215 Boehringer Ingelheim International GmbH: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 216 Boehringer Ingelheim International GmbH : Product Portfolio
  • Table 217 Catalent Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 218 Nektar Therapeutics: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 219 NEKTAR THERAPEUTICS Product Portfolio
  • Table 220 NEKTAR THERAPEUTICS: Recent Developments
  • Table 221 UCB SA: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 222 UCB SA Product Portfolio
  • Table 223 UCB SA: Recent Developments
  • Table 224 Biogen Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 225 Biogen Inc. Product Portfolio
  • Table 226 Biogen Inc.: Recent Developments
  • Table 227 Biocon: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 228 Biocon Product Portfolio
  • Table 229 Biocon: Recent Developments
  • Table 230 Regeneron Pharmaceuticals, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 231 REGENERON PHARMACEUTICALS, INC. Product Portfolio
  • Table 232 REGENERON PHARMACEUTICALS, INC.: Recent Developments
  • Table 233 Sandoz: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 234 Sandoz Product Portfolio
  • Table 235 Sandoz: Recent Developments
  • Table 236 Fujifilm Diosynth Biotechnologies: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 237 Fujifilm Diosynth Biotechnologies: Product Portfolio
  • Table 238 Sandoz: Recent Developments

List of Figures

  • Figure 1 Biologics v.s. Biosimilars Approvals by US FDA
  • Figure 2 Global Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2021-2031 (US$ million, AGR %)
  • Figure 3 Global Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2021, 2026, 2031 (%)
  • Figure 4 Global Biological Drug API Manufacturing Services Market for Outsourced Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 5 Global Biological Drug API Manufacturing Services Market for Outsourced Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 6 Global Biological Drug API Manufacturing Services Market for Outsourced Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 7 Global Biological Drug API Manufacturing Services Market for Outsourced Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 8 Global Biological Drug API Manufacturing Services Market for Outsourced Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 9 Global Biological Drug API Manufacturing Services Market for In-house Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 10 Global Biological Drug API Manufacturing Services Market for In-house Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 11 Global Biological Drug API Manufacturing Services Market for In-house Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 12 Global Biological Drug API Manufacturing Services Market for In-house Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 13 Global Biological Drug API Manufacturing Services Market for In-house Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 14 Global Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2021-2031 (US$ million, AGR %)
  • Figure 15 Global Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2021, 2026, 2031 (%)
  • Figure 16 Global Biological Drug API Manufacturing Services Market for Mammalian Cell Cultures Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 17 Global Biological Drug API Manufacturing Services Market for Mammalian Cell Cultures Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 18 Global Biological Drug API Manufacturing Services Market for Mammalian Cell Cultures Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 19 Global Biological Drug API Manufacturing Services Market for Mammalian Cell Cultures Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 20 Global Biological Drug API Manufacturing Services Market for Mammalian Cell Cultures Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 21 Global Biological Drug API Manufacturing Services Market for Microbial Fermentations Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 22 Global Biological Drug API Manufacturing Services Market for Microbial Fermentations Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 23 Global Biological Drug API Manufacturing Services Market for Microbial Fermentations Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 24 Global Biological Drug API Manufacturing Services Market for Microbial Fermentations Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 25 Global Biological Drug API Manufacturing Services Market for Microbial Fermentations Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 26 Global Biological Drug API Manufacturing Services Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 27 Global Biological Drug API Manufacturing Services Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 28 Global Biological Drug API Manufacturing Services Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 29 Global Biological Drug API Manufacturing Services Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 30 Global Biological Drug API Manufacturing Services Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 31 Global Biological Drug API Manufacturing Services Market Forecast by Application, 2021-2031 (US$ million, AGR %)
  • Figure 32 Global Biological Drug API Manufacturing Services Market Share Forecast by Application, 2021, 2026, 2031 (%)
  • Figure 33 Global Biological Drug API Manufacturing Services Market for Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 34 Global Biological Drug API Manufacturing Services Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 35 Global Biological Drug API Manufacturing Services Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 36 Global Biological Drug API Manufacturing Services Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 37 Global Biological Drug API Manufacturing Services Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 38 Global Biological Drug API Manufacturing Services Market for MABs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 39 Global Biological Drug API Manufacturing Services Market for MABs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 40 Global Biological Drug API Manufacturing Services Market for MABs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 41 Global Biological Drug API Manufacturing Services Market for MABs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 42 Global Biological Drug API Manufacturing Services Market for MABs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 43 Global Biological Drug API Manufacturing Services Market for Insulin Analogues Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 44 Global Biological Drug API Manufacturing Services Market for Insulin Analogues Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 45 Global Biological Drug API Manufacturing Services Market for Insulin Analogues Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 46 Global Biological Drug API Manufacturing Services Market for Insulin Analogues Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 47 Global Biological Drug API Manufacturing Services Market for Insulin Analogues Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 48 Global Biological Drug API Manufacturing Services Market for Interferon Therapies Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 49 Global Biological Drug API Manufacturing Services Market for Interferon Therapies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 50 Global Biological Drug API Manufacturing Services Market for Interferon Therapies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 51 Global Biological Drug API Manufacturing Services Market for Interferon Therapies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 52 Global Biological Drug API Manufacturing Services Market for Interferon Therapies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 53 Global Biological Drug API Manufacturing Services Market for Human Growth Hormones Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 54 Global Biological Drug API Manufacturing Services Market for Human Growth Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 55 Global Biological Drug API Manufacturing Services Market for Human Growth Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 56 Global Biological Drug API Manufacturing Services Market for Human Growth Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 57 Global Biological Drug API Manufacturing Services Market for Human Growth Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 58 Global Biological Drug API Manufacturing Services Market for Other Therapeutic Areas Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 59 Global Biological Drug API Manufacturing Services Market for Other Therapeutic Areas Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 60 Global Biological Drug API Manufacturing Services Market for Other Therapeutic Areas Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 61 Global Biological Drug API Manufacturing Services Market for Other Therapeutic Areas Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 62 Global Biological Drug API Manufacturing Services Market for Other Therapeutic Areas Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 63 Global Biological Drug API Manufacturing Services Market Forecast by Region 2021-2031 (US$ million)
  • Figure 64 Global Biological Drug API Manufacturing Services Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 65 Global Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 66 Global Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 67 Global Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 68 Global Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 69 North America Biological Drug API Manufacturing Services Market Forecast by Country 2021-2031 (US$ million)
  • Figure 70 North America Biological Drug API Manufacturing Services Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 71 Biologics Approved by FDA in the U.S., 2019
  • Figure 72 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 73 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 74 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 75 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 76 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 77 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 78 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 79 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 80 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 81 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 82 Europe Biological Drug API Manufacturing Services Market Forecast by Country 2021-2031 (US$ million)
  • Figure 83 Europe Biological Drug API Manufacturing Services Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 84 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 85 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 86 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 87 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 88 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 89 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 90 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 91 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 92 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 93 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 94 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 95 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 96 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 97 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 98 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 99 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 100 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 101 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 102 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 103 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 104 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 105 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 106 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 107 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 108 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 109 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 110 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 111 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 112 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 113 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 114 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 115 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 116 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 117 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 118 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 119 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 120 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 121 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 122 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 123 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 124 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 125 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 126 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 127 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 128 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 129 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Country 2021-2031 (US$ million)
  • Figure 130 Asia Pacific Biological Drug API Manufacturing Services Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 131 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 132 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 133 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 134 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 135 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 136 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 137 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 138 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 139 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 140 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 141 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 142 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 143 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 144 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 145 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 146 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 147 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 148 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 149 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 150 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 151 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 152 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 153 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 154 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 155 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 156 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 157 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 158 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 159 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 160 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 161 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 162 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 163 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 164 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 165 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 166 Latin America Biological Drug API Manufacturing Services Market Forecast by Country 2021-2031 (US$ million)
  • Figure 167 Latin America Biological Drug API Manufacturing Services Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 168 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 169 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 170 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 171 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 172 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 173 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 174 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 175 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 176 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 177 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 178 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 179 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 180 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 181 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 182 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 183 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 184 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 185 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 186 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 187 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 188 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 189 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 190 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 191 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 192 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 193 Middle East and Africa Biological Drug API Manufacturing Services Market Forecast by Country 2021-2031 (US$ million)
  • Figure 194 Middle East and Africa Biological Drug API Manufacturing Services Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 195 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 196 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 197 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 198 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 199 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 200 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 201 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 202 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 203 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 204 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 205 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 206 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 207 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 208 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 209 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 210 Bristol-Myers Squibb Co.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 211 Samsung Biologics Co., Ltd.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 212 Abbvie Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 213 GlaxoSmithKline Plc: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 214 Lonza Group: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 215 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 216 Piramal Enterprises Ltd: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 217 Boehringer Ingelheim International GmbH: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 218 Catalent Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 219 Nektar Therapeutics: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 220 UCB SA: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 221 Biogen Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 222 Biocon: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 223 Regeneron Pharmaceuticals, Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)

Companies Profiled in the Report

  • AbbVie
  • Boehringer
  • Bristol-Myers Squibb Co.
  • Cytovance Biologics
  • Fujifilm Diosynth Biotechnologies
  • GSK Biopharmaceuticals
  • Lonza Group Ltd.
  • NEKTAR THERAPEUTICS
  • Patheon N.V.
  • Samsung Biologics

List of Other Companies:

  • ACS DOBFAR
  • Array BioPharma Inc.
  • Bachem
  • Biocon
  • Biotika
  • BioXcellence
  • Celltrion
  • Centrient Pharmaceuticals
  • Daiichi Sankyo
  • Dipharma
  • DSM Biologics
  • Eisai, Co., Ltd.
  • Hisun Pharmaceuticals
  • Langhua Pharmaceutical
  • Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (FFPC)
  • Neuland Laboratories
  • Olainfarm
  • Qilu Pharmaceutical
  • STA Pharmaceutical
  • TRIFARMA
  • Uquifa
  • Yao Pharma

List of Organizations:

  • Center for Disease Prevention and Control (CDC)
  • Central Drugs Standard Control Organisation
  • Duke University School of Medicine
  • EMA (European Medicines Agency)
  • European Commission (EC)
  • European Federation of Pharmaceutical Industries and Associations
  • Human Stem Cells Institute
  • International Myeloma Foundation
  • Johns Hopkins
  • Musculoskeletal Transplant Foundation (MTF)
  • National Cancer Institute
  • New York Blood Center
  • NHS
  • NICE
  • Rice University
  • Saudi Food and Drug Authority
  • SSN Cardinal Glennon Children's Medical Center
  • The European Generic medicines Association (EGA)
  • The European Group for Blood and Marrow Transplantation (EBMT)
  • United Therapeutics
  • US Center for Disease Prevention and Control (CDC)
  • US Food and Drug Administration
  • World Bank
  • World Health Organization (WHO)